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Narcolepsy with cataplexy (NC) is a complex sleep^wake disorder, which was recently found to be associated
with a reduction or loss of hypocretin (HCRT, also called orexin).HCRT is a hypothalamic peptide implicated in
the regulation of sleep/wake, motor and feeding functions.Cataplexy refers to episodes of sudden and transient
loss of muscle tone triggered by strong, mostly positive emotions, such as hearing or telling jokes. Cataplexy is
thought to reflect the recruitment of ponto-medullarymechanisms that normally underlie muscle atonia during
REM-sleep. In contrast, the suprapontine brain mechanisms associated with the cataplectic effects of emotions
in human narcolepsy with cataplexy remain essentially unknown.Here, we used event-related functional MRI to
assess brain activity in 12 NC patients and 12 controls while they watched sequences of humourous pictures.
Patients and controls were similar in humour appreciation and activated regions known to contribute to
humour processing, including limbic and striatal regions. A direct statistical comparison between patients and
controls revealed that humourous pictures elicited reduced hypothalamic response together with enhanced
amygdala response in the patients. These results suggest (i) that hypothalamic HCRTactivity physiologically
modulates the processing of emotional inputs within the amygdala, and (ii) that suprapontine mechanisms of
cataplexy involve a dysfunction of hypothalamic^amygdala interactions triggered by positive emotions.
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Introduction
Narcolepsy with cataplexy (NC) is a disabling sleep–wake
disorder, which affects approximately 1 in 2000 individuals.
NC is characterized by excessive daytime sleepiness and
several manifestations of so-called ‘dissociated’ or isolated
rapid eye movement (REM) sleep features, such as muscle
atonia (i.e. cataplexy), sleep-paralysis and hallucinations
(Baumann and Bassetti, 2005). The pathognomonic symp-
tom of NC is cataplexy, which corresponds to short
episodes of muscle tone loss with preserved consciousness
triggered by emotions, most often by laughing or joking
(Bassetti and Aldrich, 1996; Sturzenegger and Bassetti,
2004). This striking clinical feature suggests a close
interaction between emotions, motor control and NC-
related anomalies in the brain. Human narcolepsy has
recently been found to be associated with a reduction or
loss of a hypothalamic peptide called hypocretin (HCRT,
also called orexin; de Lecea et al., 1998; Sakurai et al., 1998;
Peyron et al., 2000; Thannickal et al., 2000, 2003). HCRT is
implicated not only in sleep/wake regulation, but also in
feeding and reward functions (Mignot et al., 2002;
Baumann and Bassetti, 2005; Lu et al., 2006).
Cataplexy is explained by an inappropriate intrusion of
physiological REM sleep atonia into wakefulness
(Broughton et al., 1986; Guilleminault and Gelb, 1995).
This assumption is based on electrophysiological studies
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and clinical observations that demonstrated areflexia and
H-reflex attenuation during muscle atonia in both
REM-sleep and cataplexy (Hishikawa et al., 1965; Shimizu
et al., 1966; Guilleminault, 1976). Muscle atonia during
REM sleep results from an excitation of medullary atonia-
generating neurons which in turn inhibit spinal alpha-
motoneurons (Siegel et al., 1991). Recent data from
pharmacological (Nishino et al., 2000) and neurophysiolo-
gical (Overeem et al., 1999, 2004) studies have questioned
the concept of dissociated REM sleep symptoms and
suggest that atonia during cataplexy and REM-sleep may
be generated by distinct mechanisms but recruit common
descending ponto-medullary-spinal pathways. However, the
functional brain anatomy underlying the recruitment of
motor-atonia neurons in the brainstem by emotions
remains unknown.
Several observations support the possibility of an involve-
ment of the amygdala in cataplexy. First, electrophysiolo-
gical studies in narcoleptic dogs demonstrated changes of
neuronal firing in the amygdala during cataplexy (Gulyani
et al., 2002). Second, the amygdala was found to be strongly
activated during REM sleep in normal human subjects
(Maquet et al., 1996; Maquet and Franck, 1997). Third,
neuroimaging, neurophysiological and clinical studies have
shown that the amygdala is critically involved in emotional
information processing in both animals and humans (see
LeDoux, 2000; Zald, 2003; Vuilleumier, 2005). In addition,
the discovery of HCRT deficiency in NC suggests that the
hypothalamus represents a second main suprapontine
brain site whose dysfunction might contribute to cataplexy
in NC.
To date, imaging studies failed to reveal consistent brain
abnormalities in NC patients. Advanced neuroimaging tech-
niques could not demonstrate any systematic structural or
functional change in the hypothalamus and/or the amygdalae.
We briefly review these results hereafter.
In recent years, MRI anatomical investigations have used
voxel-based morphometry methods that allow statistical
comparisons of local tissue composition (cortex, white
matter and cerebrospinal fluid) across the whole brain.
Voxel-based morphometry studies have produced variable
results ranging from no evidence for any structural change
in NC patients (Overeem et al., 2003), through to cortical
gray matter reduction in frontal brain regions (Brenneis
et al., 2005), inferior temporal regions (Kaufmann et al.,
2002), as well as hypothalamus (Buskova et al., 2006),
cerebellum (vermis), superior temporal gyrus and right
nucleus accumbens (Draganski et al., 2002). Some other
studies used proton magnetic resonance spectroscopy to
assess in vivo neuronal loss in the hypothalamus, but found
either significant (Lodi et al., 2004) or no (Ellis et al., 1998)
such neuronal loss. Similarly, the few available functional
imaging studies provided mixed results for measures
of baseline cerebral activity in NC patients (PET, Joo
et al., 2004; SPECT, Joo et al., 2005), and for measures
of brain activity during simple sensory stimulation
(fMRI, Ellis et al., 1999) or during cataplexy attack
(SPECT, Hong et al., 2006; Chabas et al., 2007).
The main goal and methods proposed in the present study
differ from these previous brain imaging studies. Based on the
clinical observation that NC patients often have cataplexy
attacks when they experience positive emotions, we hypothe-
sized that the patients may show abnormal processing of
external emotional inputs within limbic circuits or, alterna-
tively, increased activation of efferent motor systems
(i.e. motor dysregulation induced by emotions, see for
example LeDoux, 2000; Moskowitz, 2004). To test this
hypothesis, we used a rapid event-related functional MRI
(fMRI) paradigm performed on a 3T scanner to compare
neural activity elicited by humourous versus neutral pictures
in NC patients and healthy volunteers. We predicted that
NC patients would show abnormally high fMRI activation
in some regions previously reported to respond to humourous
stimuli in normal controls, including the hypothalamus,
amygdala and ventral striatum (Goel and Dolan, 2001; Mobbs
et al., 2003; Moran et al., 2004; Watson et al., 2006, for review
see Wild et al., 2003). Our high-resolution fMRI study
provides the first assessment of regional brain responses to
positive emotions in human narcolepsy.
Methods
Subjects
Twelve drug-free narcoleptic patients with clear-cut cataplexy
(based on clinical examination and standard questionnaires;
The International Classification of Sleep Disorders, 2005) and 12
healthy volunteers (matched for age, gender and body-mass index)
provided written informed consent to participate in an fMRI
study which was approved by the local ethics committee (Tables 1
and 2). The patients’ Epworth Sleepiness score (ESS; Johns, 1991)
was 15.6 4.2 (mean  SD; range: 7 to 21), the Ullanlinna
Narcolepsy Scale (UNS; Hublin et al., 1994) was 22.4 8.5 (9 to
36), the Swiss narcolepsy scale (SNS; Sturzenegger and Bassetti,
2004) was 42.7 35.4 (101 to 11) and the Stanford cataplexy
scale (Anic-Labat et al., 1999) showed a mean of 74.2 26.2%
(32.5 to 91.7) (see Tables 1 and 2 for detailed scores); patients
differed from the controls on all these scales [all F(1,22)438,
P50.001]. HLA typing was positive for all patients
(HLA-DQB10602 for 11 patients and DR2 for one patient).
CSF-hypocretin assessment was obtained in eight patients and
hypocretin was not detectable in six patients and reduced
(112.5 7.8) in two patients. In all patients, pharmacological
treatments were discontinued for at least 14 days prior to the
experimental day and at least five elimination half-life times of the
respective substances before entering the experiment. Note that we
had to exclude two patients from an initial group of 14 patients
because they felt asleep during one scanning run. We also
excluded the two controls matching these patients from further
analyses. Based on the behavioural responses collected during
scanning and on detailed questioning after each scanning run,
we can rule out that any of the 12 patients included in the results
had a cataplexy attack during scanning.
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Humour judgement paradigm
Stimuli
We selected 100 humourous and 100 corresponding neutral
pictures matched for visual complexity and content (objects,
characters, animals and actions depicted), as well as for mean
luminance. We obtained two additional series of 100 neutral
pictures from this initial set of stimuli by removing the
humourous element in each humourous picture and an equivalent
element in each neutral scene. We could thus create mini-
sequences with a first picture that was always neutral followed by a
second picture that revealed either a humourous or a neutral
element (Fig. 1). Twenty-six subjects who did not take part in the
fMRI experiment rated these 200 mini-sequences for humour
intensity on a 0 to 3 scale (‘neutral’ to ‘very funny’). For the fMRI
experiment, we selected the 39 funniest sequences (mean humour
intensity: 2.2) and the 39 neutral sequences matching these funny
sequences (all rated neutral). During scanning, the stimuli covered
8 8 degrees of visual angle and were displayed using E-prime
software (Psychology Software Tools, Pittsburgh, PA) allowing for
precise response recording and synchronization with fMRI
acquisition.
Table 1 Clinical characteristics of narcoleptic patients and control subjects






ESS Stanford (%) UNS SNS
Patientsa
1 22 F 15.8 + 107 + 4 20 32.5 34 101
2 30 F 28.2 + 520 + 7 19 91.7 36 68
3 33 F 24.2 + 520 + 19 16 91.7 24 66
4 36 F 33.7 + na + 18 10 45.8 9 29
5 39 F 43 + na + 18 15 91.7 23 68
6 43 F 20.8 + 520 + 15 19 32.5 18 11
7 19 M 24 + 520 + 1 21 91.7 20 7
8 25 M 32.3 + 520 + 9 7 45.8 11 37
9 27 M 41.1 DR2 + na + 20 16 91.7 21 28
10 33 M 34.6 + na + 27 12 91.7 25 42
11 39 M 26.2 + 118 + 18 17 91.7 16 6
12 45 M 34.7 + 520 + 3 15 91.7 32 83
Controlsb
1 22 F 19.5 na na na na 8 0.6 4 31
2 30 F 19.4 na na na na 4 0.6 4 27
3 31 F 22.6 na na na na 10 32.5 7 16
4 40 F 39.9 na na na na 3 0.6 2 36
5 42 F 39 na na na na 11 0.6 3 39
6 40 F 23.8 na na na na 5 0.6 3 15
7 25 M 29.7 na na na na 3 0.6 2 33
8 28 M 28 na na na na 5 0.6 4 11
9 31 M 31.9 na na na na 6 0.6 4 21
10 36 M 27.2 na na na na 11 0.6 13 27
11 39 M 24.7 na na na na 6 0.6 8 43
12 42 M 21 na na na na 6 0.6 1 9
aMean age (SD): 32.6 8.3.
bMean age (SD): 33.8 6.9.
Note: Patients were selected by a team of neurologists with extensive experience in narcolepsy (C.B., E.W., R.K.). They were all off
medication for at least 14 days prior to the experimental day. All the patients reported cataplexy episodes following positive or arousing
emotions such as laughing (12/12 patients), telling or hearing a joke (10/12), as well as being surprised (10/12), emotionally moved (8/12) or
excited (7/12). na=not applicable; HCRT=hypocretin-1 level in CSF (normal values4320pg/ml;520=concentration below detection
limit of assay); BMI=body mass index; ESS=Epworth Sleepiness Scale (0^24, higher scores indicate increased self-reported sleepiness cut
off score410); Stanford=Stanford cataplexy questionnaire (probability for clear cut cataplexy432.5%);UNS=Ullanlinna Narcolepsy Scale
(suggestive of narcolepsy if414); SNS=Swiss-Narcolepsy Scale (suggestive of narcolepsy if50).






Naps SOREM REM latency
(min)
1 3.8 5 3 5.5
2 1 4 4 3.5
3 na na na na
4 5 5 3 11.2
5 na na na na
6 2.1 4 3 3.3
7 1.4 4 4 3
8 1 4 4 1.4
9 1.5 5 5 3.4
10 1.8 5 3 5
11 0.9 4 4 2.1
12 0.3 4 4 1.4
Note: The MSLTwas measured across five naps at 2h intervals,
starting between 9 and 10 am.‘Naps’ correspond to the number of
naps during which the patients felt asleep, and sleep onset REM
period (SOREM) is defined as one or more epochs of REM sleep
occurring within 15min of the first 30 s epoch scored as sleep.
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Task
All participants were scanned while they watched 78 humourous or
neutral picture-sequences (Fig. 1). On each trial, the participants
judged whether they found the sequence funny or not (by pressing
one of two keys; optic fibre response pad, Current Design,
Philadelphia, PA).
MRI acquisition
Whole-brain event-related fMRI data were acquired on a Philips
Intera 3.0-Tesla whole-body system (Philips Medical Systems, Best,
NL) equipped with an eight-element head coil array (MRI Devices
Corporation, Waukesha WI), using sensitivity-encoded single-shot
echo-planar sequence (SENSE-sshEPI). Functional volumes con-
sisted of 36 contiguous axial slices positioned parallel to the
AC–PC plane and covering the whole brain with a spatial
resolution of 1.8 1.8 3.9mm3 (FoV= 220mm, TE= 35ms,
TR= 2.2 s, SENSE reduction factor R= 2.0). The scanning para-
meters were optimized during pilot testing to minimize suscept-
ibility-related signal losses in orbito-frontal cortex and inferior
temporal regions. Careful examination of each individual set of
data confirmed that there was no signal drop in hypothalamic and
amygdala regions reported in the results section. Functional
images (n= 390) were acquired across three scanning runs
separated by brief pauses. High-resolution 3-D T1-weighted scan
was obtained for anatomical reference and volumetric analyses
(voxel-size = 0.9 0.9 0.75mm3).
MRI data analysis
Processing and statistical analyses of imaging data were performed
with SPM2 (www.fil.ion.ucl.ac.uk). Functional scans were rea-
ligned, corrected for slice timing, normalized to the MNI template
(resampled voxel size: 3 3 3mm3), and spatially smoothed
(8mm Gaussian kernel). Whole-brain statistical analyses were
conducted on individual time-series using the general linear model
with two main regressors coding for neutral and humourous trials
(second pictures in sequence; Fig. 1), as classified by each
participant during fMRI, convolved with a canonical hemody-
namic response function. Additional covariates of no interest
included onset-times for the first pictures (always neutral), as well
as movement parameters from realignment correction to account
for residual movement artefacts. Statistical parametric maps were
generated from linear contrasts between conditions in each parti-
cipant. The (humour4neutral) contrast images from each subject
were submitted to a second-level group analysis, using a two-way
ANOVA treating subjects as a random effect.
In the ‘Results’ section, we first describe effects found in
patients and controls using conjunction analyses to preserve only
voxels that were significant in the contributing SPM maps of both
populations (Friston et al., 2005). We then report group compa-
risons performed using exclusive masking to reveal voxels showing
significant activation for the contrast (humour4neutral) in one
population but no such effect whatsoever in the other population
for the exact same contrast. SPM exclusive masks were thres-
holded at P50.05, whereas the contrasts to be masked were
thresholded at P50.001. Note that the more liberal the threshold
of an exclusive mask, the more conservative is the masking
procedure. For the patient group, we performed additional whole-
brain second-level correlations analyses between the contrast
(humour4neutral) and the main clinical measurements, including
age at disease onset, duration of disease, sleepiness and each of the
cataplexy scores (see earlier). These analyses allowed us to assess
whether the modulation of brain responses to humour might
relate to individual clinical characteristics.
Results
Behaviour
During scanning, patients and controls did not differ in the
proportion of images judged as humourous (mean
percentage SD, 40.06 7.64 and 41.67 6.59, respec-
tively). As expected from excessive daytime sleepiness in
NC, patients were generally slower than control [reaction
times: ms SD, 789.04 120.26, 607.36 121.65,
Fig. 1 Stimulus sequence. Each trial was composed of a first neutral scene followed by a second picture revealing a new element either
neutral or humourous. Subjects made a humour judgement response after the offset of the second picture. Inter-stimulus interval varied
from 8.8 to 15.4 s.
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respectively; F(1,22) = 13.97, P50.01], but without any
effect of picture-type (neutral, humourous) and no
interaction of group by picture-type.
Functional MRI: main effect of humour
Using a conjunction analysis, we first identified brain
regions that responded to humourous compared to neutral
trials in both patients and controls (Table 3). This analysis
revealed activation in limbic (amygdala and insula) and
frontal regions known to be recruited by the affective
content of humourous inputs and experience (Mobbs et al.,
2003; Moran et al., 2004; Watson et al., 2006). Additional
activity increase was observed in visual regions, possibly
involved in the maintenance and processing of information
necessary for the appreciation of humourous pictures
(Goel and Dolan, 2001).
Increased brain response to
humour in controls
We then tested for regions showing increased fMRI signal
during humourous (versus neutral) trials in controls
but not in patients. Controls showed a maximal activity
difference in the right hypothalamus (peak at 12x, 3y,
18z), whereas patients did not show any humour-related
modulation in the hypothalamus (Fig. 2 and Table 3).
This result is consistent with a hypothalamic dysfunction in
our patients (Mignot et al., 2002; Baumann and Bassetti,
2005).
Controls also showed increased activity in the anterior
cingulate, left anterior insula, orbitofrontal cortex and
medial prefrontal cortex, a network of regions previously
associated with hedonic experience and autonomic control
(Critchley et al., 2004; Kringelbach, 2005), as well as with
emotional regulation and learning (Hariri et al., 2003;
Phelps et al., 2004).
Increased brain response
to humour in NC patients
When compared to controls, NC patients showed increased
response to humourous stimuli in the right amygdala
(Fig. 3). The patient-selective activation lied in a more
lateral and anterior region of the amygdala than the
Table 3 Regional brain responses to humour versus neutral ratings
Region MNI coordinates
L/R x y z BA Z-score
Main effect for [humour4neutral] contrast
Group conjunction with controls and patients
Fusiform cortex L 45 51 18 37 4.07
R 48 63 15 37 3.97
Insula/Inferior frontal L 42 18 3 47/48 3.47
Middle occipital gyrus L 39 87 6 18/19 3.45
Superior medial frontal L 12 39 45 9 3.44
Amygdala R 18 6 18 ^ 3.21
Amygdala L 21 6 21 ^ 3.10
Group comparison for [humour4neutral] contrast
Controls4Patients using exclusive masking procedure
Hypothalamus R 12 3 18 ^ 4.55
Anterior cingulate L 9 45 15 32/24 4.54
Orbitofrontal R 27 12 21 38 4.00
Lateral occipital R 42 78 6 19 3.91
Orbitofrontal/insula L 27 24 18 38/47 3.88
Inferior frontal gyrus L 48 18 15 48 3.84
Anterior cingulate R 0 18 36 24 3.84
Insula R 45 18 12 47 3.83
Medial prefrontal R 12 60 3 10 3.71
Group comparison for [humour4neutral] contrast
Patients4Controls using exclusive masking procedure
Supramarginal gyrus R 57 33 27 48/2 4.17
Insula L 36 3 6 48 4.07
Posterior cingulate L 9 45 33 23/26 4.05
Inferior frontal gyrus R 51 30 3 45 3.94
Fusiform cortex R 33 57 15 37 3.70
L 39 60 12 37 3.48
Ventral striatum (N. accumbens) L 15 9 3 ^ 3.52
Amygdala R 33 3 21 ^ 3.14
Note: Stereotactic coordinates correspond to the standard Montreal Neurological Institute (MNI) brain. Reported regions survived
a threshold level of P50.001 uncorrected, or a threshold of P50.05 corrected (small volume correction using a 9mm radius sphere,
indicated by an asterisk). Mask threshold for group comparisons was set at a conservative level of P50.05.
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activation revealed by the group conjunction. Increased
activity in right inferior parietal and in fusiform cortex in
the patients might reflect the impact of top-down
influences from the amygdala on sensory pathways, which
can prioritize the representation of emotional events
within attentional and perceptual systems (Vuilleumier,
2005). Humour-selective increases in NC patients were
also observed in other regions contributing to the
integration of emotion and reward-related functions
(Price, 2005) with more activity in inferior frontal cortex,
insula and ventral striatum, including left nucleus accum-
bens (Fig. 4, Table 3).
Additional whole-brain correlation analyses using indivi-
dual clinical characteristics of the patients as regressors
(see ‘Methods’ section) did not disclose any signifi-
cant linear relationship with activity levels within these
regions.
Discussion
We report here the first event-related fMRI data obtained
on NC patients while they experienced positive emotion.
Our results reveal that narcolepsy is associated with
increased amygdala activity together with reduced medial
prefrontal and hypothalamic activity during humour
processing.
A recent SPECT study in two patients reported increased
neuronal activity in the amygdala during cataplexy attacks
triggered by emotions (Hong et al., 2006, for related animal
results, see Gulyani et al., 2002). However, another
SPECT study did not replicate this finding in one patient
Fig. 2 Increased response to humour in right hypothalamus, medial prefrontal and cingulate cortex for controls relative to
NC patients. Parameter estimates extracted from hypothalamic peak illustrate selective activation for humourous stimuli in
the controls but not in the patients. Statistical maps are overlaid on mean-normalized T1-structural scan.
Fig. 3 Increased amygdala response to humour in NC patients compared to controls. Parameter estimate showed increased fMRI
signal to humourous sequences in the patients but not in the controls. Statistical maps are overlaid on mean-normalized T1-structural scan.
Fig. 4 Increased fMRI signal in left insula and nucleus accumbens
in NC-patients (but not in controls). Clusters of activation are
overlaid on the mean-normalized T1-weighted structural scan.
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(Chabas et al., 2007). It is noteworthy that, in this second
study, the patient’s cataplexy attack had not been triggered
by any particular emotion. Our results on a group of 12 NC
patients do not only add support to, but also go beyond
these observations by providing the first demonstration
that narcolepsy disease is associated with exaggerated
amygdala response to transient humour stimuli—even in
the absence of any cataplexy episodes. These findings
suggest that elevated amygdala response to positive




All patients included in our study reported joking and
laughing as a main trigger of cataplexy attacks. Behaviour-
ally, NC patients and their matched controls exhibited a
similar response profile during the humour appreciation
task, with the same proportion of stimuli judged funny in
both groups and no reaction times difference between
funny and neutral stimuli. Thus, the observed differences in
brain activation cannot be attributed to some general
alteration of perceived affective values or to emotional
suppression strategies that the patients might use to protect
themselves from cataplexy (note that the latter would rather
lead to decrease in limbic activity; see Phan et al., 2005).
At the brain level, the present fMRI data reveal that NC
patients showed increased brain response to humourous
stimuli in several regions associated with emotional and
reward processing. We also observed increased activity
in attentional and sensory regions, possibly reflecting
enhanced perceptual processing of emotional stimuli
mediated by direct feedback signals imposed by amygdala
on cortical pathways (Vuilleumier, 2005). These findings
therefore provide a neural basis for the patients’ subjective
reports and well-documented clinical observations that
positive emotions often trigger abnormal reactions such as
cataplectic attacks in NC patients.
While it is generally accepted that connections from
the amygdala to the hypothalamus can modulate reflex
responses to emotional stimuli (LeDoux, 2000; Sullivan et al.,
2004; Price, 2005), our new fMRI results suggest that the
hypothalamus might also have modulatory influences on
amygdala activity during positive emotions, possibly via direct
projections from hypothalamic HCRT neurons to the
amygdaloid complex (Peyron et al., 1998; Date et al., 1999;
Marcus et al., 2001; Bisetti et al., 2006). Reduced hypotha-
lamic activation and exaggerated amygdala response to
humour could be due to loss of hypothalamic HCRT neurons
in NC. Another neural circuit possibly mediating a regulatory
action of HCRT on affective responses has recently been
identified and implicates projections of HCRT onto the
ventral tegmental area (VTA; Fadel et al., 2002). These
projections might act to increase dopamine (DA) efflux in
the prefrontal cortex and increase time spent awake based on
motivational signals (Vittoz and Berridge, 2006; see also
Wisor et al., 2001). Critically, activity in prefrontal cortex and
anterior cingulate might be involved in the suppression of
amygdala response (Hariri et al., 2003), and was found to
mediate extinction in conditioning paradigms in both animals
and humans (Milad and Quirk, 2002; Phelps et al., 2004).
Thus, the reduced hypothalamic and prefrontal activity
together with increased amygdala activation in NC patients
found in the present study could reflect a dysfunction of
HCRT/DA-mediated pathways that usually inhibit amygdala
activity, but could lead to an abnormally high amygdala
response to positive emotions in narcolepsy.
Other brain regions showed different responses in NC
patients and controls. Although animal research has shown
that HCRT neurons send widespread projections to the
entire CNS (Peyron et al., 1998; Date et al., 1999; Sakurai,
2007), one should remain cautious when interpreting all of
these regional changes as primarily reflecting modulations
at direct HCRT projection sites. Alternatively, some changes
may reflect indirect consequences from abnormal HCRT
activity within networks associated with emotion and
arousal.
Our human imaging data also show that NC patients
have elevated fMRI responses to humour in the left nucleus
accumbens, a key component of the mesolimbic reward
system known to be involved in humour processing
(Mobbs et al., 2003), and which has strong interconnections
with the amygdala, prefrontal cortex and thalamus (Price,
2005). Increased activity in the nucleus accumbens
could be secondary to increased amygdala activity, or
might result from a disruption of direct HCRT modulation
on reward systems (Harris et al., 2005; Narita et al., 2006).
An effect of HCRT depletion on the behavioural response
to reward is well-documented as it has been reported that
NC patients rarely become addicted to stimulants (Bassetti
and Aldrich, 1996) and HCRT knockout mice show
attenuated withdrawal response to morphine (Georgescu
et al., 2003).
However, the present fMRI data alone do not allow us to
determine the exact role of the striatum in emotional
responses to humour in NC, and the possible relations to
motor effects associated with cataplexy. Further research is
warranted to clarify how HCRT depletion might differen-
tially affect distinct functional divisions of the striatum
linked to reward processing (e.g. sensorimotor versus limbic
processes; Voorn et al., 2004).
Taken together, our findings provide evidence for an
implication of amygdala circuits in the pathophysiology of
human narcolepsy and abnormal responses to positive
emotions in these patients, as clinically observed during
cataplexy. Furthermore, these data support recent proposals
suggesting a key role of the human HCRT system in
modulating activity in hypothalamus-limbic circuits that
are involved in the integration of emotion, reward and
sleep processes.
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